Navigation Links
Misonix Restructures and Expands Sales Organization in Europe
Date:9/2/2009

N) designs, develops, manufactures and markets therapeutic ultrasonic medical devices and laboratory equipment. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at www.misonix.com.

With the exception of historical information contained in this press release, content herein may contain "forward looking statements" that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include general economic conditions, delays and risks associated with the performance of contracts, risks associated with international sales and currency fluctuations, uncertainties as a result of research and development, acceptable results from clinical studies, including publication of results and patient/procedure data with varying levels of statistical relevancy, risks involved in introducing and marketing new products, potential acquisitions, consumer and industry acceptance, litigation and/or court proceedings, including the timing and monetary requirements of such activities, the timing of finding strategic partners and implementing such relationships, regulatory risks including approval of pending and/or contemplated 510(k) filings, the ability to achieve and m
'/>"/>

SOURCE Misonix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Misonix To Present at The Rodman & Renshaw 10th Annual Healthcare Conference
2. Misonix Subsidiary, Sonora Medical Systems, Announces a Major Ultrasound Probe Study
3. Misonix Schedules First Quarter Fiscal Year 2009 Financial Results Conference Call; November 13, 2008 at 4:30 P.M. Eastern
4. Misonix Reports First Quarter Fiscal Year 2009 Financial Results
5. Misonix Announces Extension and Expansion of Distribution Agreement With Mentor Corporation
6. Misonix Announces New HIFU Distribution Agreement for Italy
7. Misonix Schedules Second Quarter Fiscal Year 2009 Financial Results Conference Call; February 9, 2009 at 4:30 P.M. Eastern
8. Misonix Reports Earnings and Increased Revenues for the Three and Six Months Ended December 31, 2008
9. Misonix Announces New Distribution Agreement for Israel
10. Misonix Announces New Sales Agency Agreement for Eastern Europe
11. Misonix Announces New Distribution Agreement for Belgium and Luxembourg
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... 28, 2015 March—also known as ... to remind ourselves and others that suspected head ... NeuroSurgical Specialists (ANS). , Concussions are a form ... 75% of TBIs. There are 1.6-3.8 million sports-related ... benign, but it is a brain injury. Many ...
(Date:2/28/2015)... February 28, 2015 Indosoft Inc ... suite for Asterisk, are pleased to announce the development ... 5.7 and 5.8 versions of Q-Suite, this new version ... a number of new features to the leading edge ... , Q-Suite 5.9 will add features to enhance security ...
(Date:2/28/2015)... February 28, 2015 The Mesothelioma ... annual awards at the International Symposium on Malignant Mesothelioma ... held at the Hyatt Regency Bethesda in Bethesda, Maryland. ... dedicated work and commitment to the mission to cure ... Award will be presented to Miriam Ratner. Miriam runs ...
(Date:2/28/2015)... 28, 2015 Dr. Perry Patel ... area residents, recently announced a special offer for the ... treatment option for new and established patients at his Pismo ... a bright, white smile, Dr. Patel and his staff ... marked down from the regular price of $450. , ...
(Date:2/28/2015)... Kaylie Corrigan, Outdoor Supervisor at Back2Basics ... current student obtaining her Masters degree in social work ... in psychoeducation on substance use for teens at the ... of her studies. , “Even though these students are ... at the high school and junior high school level,” ...
Breaking Medicine News(10 mins):Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3Health News:Indosoft Proudly Announces Q-Suite 5.9 Call Center Software for Asterisk 2Health News:Cancer Research Foundation Honors Award Recipients 2Health News:Cancer Research Foundation Honors Award Recipients 3Health News:Cancer Research Foundation Honors Award Recipients 4Health News:Pismo Beach Dentist Announces Special for Zoom! Teeth Whitening 2Health News:Staff at Arizona Drug Addiction Treatment Center Starts Teen Sobriety Support Group at Local High School 2
... could slow start of malignancies , WEDNESDAY, Oct. 7 ... with HIV puts them at increased risk for at ... treatment of HIV infection could help delay the onset ... , French researchers examined the incidence of three AIDS-defining ...
... Health care coverage is on a lot of people,s minds ... considerable amount of money on your health care at work, ... process. , Listen to this report from OptumHealth at: ... audio, text, graphics and photos for free and unrestricted use ...
... Back-to-school means back to hitting the books. Yet this year, ... book to her students in grades five through eight. The ... for kids, will teach students at St. Francis de Sales ... making nutritious food choices, while balancing their tasks at school ...
... European study finds no survival difference for those with, without ... defibrillator in the first weeks after a heart attack does ... deaths from sudden cardiac arrest occurred among those given the ... overall death rate was about the same as for those ...
... A trial beginning next week targeting the nation,s largest ... denying requests for out-of-network liver transplants will help shed ... is currently being considered, according to Consumer Watchdog. The ... national news media to follow the trial. , ...
... RATON, Fla., Oct. 7 Coverall Health-Based Cleaning System(SM), a ... has been recognized as one of the "50 Top ... (NMFI) for the third year in a row. The ... section of USA Today, the national daily newspaper. Coverall ...
Cached Medicine News:Health News:HIV Patients More Prone to 7 Kinds of Cancer 2Health News:A School Assignment That May Add Years to a Child's Life 2Health News:A School Assignment That May Add Years to a Child's Life 3Health News:Early Defibrillator After Heart Attack May Not Pay Off 2Health News:Early Defibrillator After Heart Attack May Not Pay Off 3Health News:National Health Care Reformers Should Pay Attention to Lawsuit Alleging that Nation's Largest Insurer Routinely Denies Liver Transplants 2Health News:Coverall Named Among '50 Top Franchises for Minorities' for Third Consecutive Year 2
(Date:2/26/2015)... Calif. , Feb. 27, 2015  Finesse expands office ... Finesse Solutions announced the expansion of its operations ... is planned for mid-March and access for customers is ... the A-563, and located adjacent to the current office, ... the Finesse automation engineering team and allow Finesse to bring ...
(Date:2/26/2015)... 26, 2015  AbbVie (NYSE: ABBV ... in its neuroscience and oncology development programs have ... American Academy of Neurology annual meeting in ... 18-25. The accepted abstracts feature results from studies ... investigational treatments in AbbVie,s pipeline. Presentations will include ...
(Date:2/26/2015)... 26, 2015  Mobility Ventures LLC, an AM General ... of America (NYSE: BAC ) that will ... of the revolutionary MV-1 - - the world,s first ... up to provide safe and comfortable transportation for all ... loan to purchase a new MV-1 vehicle at the ...
Breaking Medicine Technology:New Finesse Office in United Kingdom 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 3
... VIEW, Calif., July 24 Alexza,Pharmaceuticals, Inc. ... it has initiated,its second Phase 3 clinical ... inhalation product candidate being developed for the ... or bipolar disorder.,Alexza believes the novel, non-invasive ...
... Program Speeds Oncology Patient Accrual, DENVER, ... Management,Organization (RMO), has contracted with five leading ... services for their,clinical trials using the Just-in-Time ... following disease indications: follicular Non-Hodgkin,s,Lymphoma, Metastatic Breast ...
Cached Medicine Technology:Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials 2
ROC XS is a polyethylene implant used for soft tissue reattachment to bone. The umbrella-like deployment of this anchor provides increased fixation strength. This anchor is easy-to-insert using the R...
The Knotless Anchor, a titanium alloy implant, is used for soft tissue reattachment to bone. The Knotless Anchor is indicated for open and arthroscopic Bankart repairs....
... The Linvatec 5mm Super Revo Suture Anchor ... arthroscopic or a mini-open rotator cuff repair. ... the anchor is pre-threaded with two #2 ... pitfalls of suture management are avoided with ...
The 4mm diameter Revo suture anchor is designed primarily for arthroscopic and open rotator cuff repair. Additional applications include other shoulder repair procedures, as well as use in knees and ...
Medicine Products: